ZENYAKU KOGYO CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1950-01-01
- Employees
- 501
- Market Cap
- -
Clinical Trials
29
Active:1
Completed:23
Trial Phases
4 Phases
Phase 1:3
Phase 2:6
Phase 3:5
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials
Not Applicable
11 (44.0%)Phase 2
6 (24.0%)Phase 3
5 (20.0%)Phase 1
3 (12.0%)A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies
- First Posted Date
- 2012-09-11
- Last Posted Date
- 2017-07-06
- Lead Sponsor
- Zenyaku Kogyo Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01682473
- Locations
- 🇯🇵
National Cancer Center Hospital East, Kashiwa-city, Chiba, Japan
🇯🇵The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan
A Safety Study of Oral ZSTK474 in Patients With Cancer
- First Posted Date
- 2011-01-20
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Zenyaku Kogyo Co., Ltd.
- Target Recruit Count
- 39
- Registration Number
- NCT01280487
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Washington University, St Louis, Missouri, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
News
No news found